Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Military Investigates Supplement Ingredient DMAA, Bans Sales

This article was originally published in The Tan Sheet

Executive Summary

DoD suspends DMAA sales at military stores after regulators in Canada and New Zealand restricted access and as some U.S. firms change how they market and label the ingredient. These moves and the potential for an FDA review could lead to enforcement against DMAA similar to the 2004 ban against ephedra’s use in supplements.

Advertisement

Related Content

Las Vegas Kratom Marketer Rolls Dice On FDA's Mandatory Recall Authority
DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage
DoJ Enlists Supporting Cast Against ‘Bad Actors’ On Supplement Stage
Military Report Slams DMAA While GNC Claims Victory
Military Report Slams DMAA While GNC Claims Victory
FDA Using “All Available Tools” To Remove DMAA From Market
Ephedra Back On Regulatory Radar As Supplement Adulterant
Supplement Industry Must Step Up As Adulteration Threat Grows – FDA
Hydroxycut Recall Eyed As Trigger For Closer Look At Supplement AERs
FDA Regulatory Framework For Ephedra Ban Expected To Get Court Review

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105495

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel